The chapter
Population-scale precision medicine depends on turning biological insight into interventions that are safe, manufacturable, and regulator-ready while adapting to genotype, phenotype, exposures, and disease state. As of 2026, mRNA is a validated prophylactic platform and is expanding into oncology and other therapeutics, but progress is limited by delivery and dosing precision in heterogeneous patients. Circular RNA is being explored to tune stability and expression duration. Continued evidence synthesis on COVID-19 mRNA vaccines keeps refining mechanisms and safety, underscoring surveillance and interpretability for real-world deployment.
This record lists the chapter's canonical sources and its revisions as recorded on Comuvia's BookWriter and MediaManager systems. The chapter and its video are AI-authored and AI-produced; the sources ground the text, they do not endorse it.

Sources
The chapter's canonical source pack as recorded on BookWriter: milestone papers, patents and news found through Crossref, OpenAlex, USPTO and news providers. Tier reflects citation strength, not Comuvia's endorsement.
| # | Type | Source | Tier | Found via |
|---|---|---|---|---|
| 1 | Paper | The CRISPR Patent Ruling and Implications for Medicine Paradise, Jordan · JAMA · 2023 · doi:10.1001/jama.2022.24986 | gold · highly cited | crossref |
| 2 | Paper | The “All of Us” Research Program New England Journal of Medicine · 2019 · doi:10.1056/nejmsr1809937 | gold · highly cited | crossref |
| 3 | Paper | Application of mRNA Technology in Cancer Therapeutics Eralp, Yesim · Vaccines · 2022 · doi:10.3390/vaccines10081262 | strong | crossref |
| 4 | Paper | Circular RNA Therapeutics and Vaccines Liu, Xiang et al. · Trends in mRNA Vaccine Research · 2024 · doi:10.1002/9783527838394.ch5 | strong | crossref |
| 5 | Paper | From Rejection to Revolution: mRNA Vaccines Go Beyond Infections to Diseases in the Brain Grinstein, Jonathan D. · Inside Precision Medicine · 2025 · doi:10.1089/ipm.12.03.11 | strong | crossref |
| 6 | Paper | mRNA therapeutics beyond vaccines: dosing precision challenges and clinical translation framework Niazi, Sarfaraz K. · RSC Pharmaceutics · 2026 · doi:10.1039/d5pm00159e | strong | crossref |
| 7 | Paper | mRNA Vaccine Technology Beyond COVID-19 Oloruntimehin, Sola et al. · Vaccines · 2025 · doi:10.3390/vaccines13060601 | strong | crossref |
| 8 | Paper | mRNA vaccines Hillery, Anya M · mRNA Therapeutics · 2025 · doi:10.1016/b978-0-443-28934-7.00009-1 | strong | crossref |
| 9 | Paper | Evidence-based assessment of safety and mechanistic questions Related to mRNA COVID-19 Vaccines Sohn, Woo Yun et al. · Vaccine · 2026 · doi:10.1016/j.vaccine.2026.128394 | strong | crossref |
| 10 | Paper | mRNA Therapeutics Beyond Vaccines: A Platform Technology for Cancer, Autoimmune, and Genetic Disorders Obi, Obi Blessing · 2026 · doi:10.2139/ssrn.6141686 | strong | crossref |
| 11 | Paper | mRNA vaccines for COVID-19 Hillery, Anya M · mRNA Therapeutics · 2025 · doi:10.1016/b978-0-443-28934-7.00005-4 | strong | crossref |
| 12 | Paper | mRNA Innovates the Vaccine Field Pardi, Norbert · Vaccines · 2021 · doi:10.3390/vaccines9050486 | strong | crossref |
Revisions
| When | Event | Detail |
|---|---|---|
| May 5, 2026 | Source pack version | version 1 · refresh coverage gap · 12 entries |
| May 6, 2026 | Source check | pass · coverage 100 % |
| Aug 27, 2026 | Upload (full) | uploaded · YaymCkLRSJU |
| Aug 27, 2026 | Upload (short_15s) | uploaded · 9UnqMroGZlQ |
| Sep 2, 2026 | Published on the channel | upload date as listed on the channel · Ilv748CRkwo |
About this record
Book: The Long Horizon: A Vision of Frontier Technology from 2026 to 2400 (BookWriter (Comuvia S2)). Channel: Comuvia Vision. Sources are the chapter's canonical source pack in BookWriter (milestone papers, patents and news found through Crossref, OpenAlex, USPTO and news providers; tiers gold/strong by citation strength); revisions are the pack versions, the compliance checks and the campaign's uploads. The chapter text itself is AI-authored on BookWriter; the sources ground it, they do not endorse it.
anchor 3c4d523c-ac7f-4dfd-935c-2d9464d5e3a9 · thread 65baf87d-0fa5-4a7e-9f21-d155ab0f7de4